Closed · HRSA-20-076 · CFDA 93.928 · Discretionary

Rapid Antiretroviral Therapy (ART) Start in the Ryan White HIV/AIDS Program – Dissemination Assistance Provider

Federal grant opportunity posted by Health Resources and Services Administration, cataloged on Grants.gov.

up to $1M
Award range
Closed
Status
March 3, 2020
Close date
1
Expected awards

The verdict

Rapid Antiretroviral Therapy (ART) Start in the Ryan White HIV/AIDS Program – Dissemination Assistance Provider is a closed discretionary listing from Health Resources and Services Administration that offered Up to $1,000,000 across 1 expected award. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 1,731 other opportunities from Health Resources and Services Administration.

up to $1M
award range
Closed
application status
1
expected award
93.928
CFDA program

Archived opportunity record

Rapid Antiretroviral Therapy is closed (last close March 3, 2020). Check the agency catalog for replacement NOFOs. Health Resources and Services Administration still indexes 1,731 other opportunities here.

According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.

Deadline tracker

Application window closed

Closed March 3, 2020

Posted Nov 15 Closes Mar 3

Est. Total Funding

$1,000,000

Expected Awards

1

Instrument

Grant

Description

This notice announces the opportunity to apply for fiscal year (FY) 2020 funding under the new 3-year program entitled Rapid Antiretroviral Therapy (ART) Start in the Ryan White HIV/AIDS Program – Dissemination Assistance Provider. The purpose of this Health Resources and Services Administration (HRSA) program is to fund a single organization that will develop a compendium of promising rapid ART interventions. The recipient will systematically identify and document innovative practices and procedures of rapid ART interventions and promote the dissemination of these models for replication among RWHAP and other providers serving people with HIV. Specifically, the intent of this program is to: 1) perform a comprehensive environmental scan to compile a collection of effective rapid ART interventions for people with HIV who are newly diagnosed and not currently engaged in care; 2) examine current policies in the administration of existing rapid ART start models at the clinic level and in system wide settings; 3) document and disseminate successes, barriers and challenges of identified models and interventions; 4) assess the adaptability of successful models and interventions employed; and 5) promote the replication of effective models and interventions among RWHAP and other providers serving people with HIV. Examples of rapid ART models and interventions may include, but are not limited to: 1) Models and interventions which have shown effectiveness in accelerating the time from new HIV diagnosis to entry into care and initiation of ART treatment, including rapid eligibility determination for RWHAP services, 2) Models and interventions that demonstrate improved retention in care, and 3) Models and interventions that demonstrate impact of a reduced time between initiating rapid ART and viral suppression, as well as having a sustained virological response.

Catch-all / unrestricted eligibility mark · HRSA-20-076

Grants.gov marks Rapid Antiretroviral Therapy with a catch-all / unrestricted eligibility code (Others (see official listing text)). Read the official announcement text for the real applicant filter — the code alone is not a door list. The extract does not mark applicant cost-sharing as required. Instrument: Grant. Funding-activity code maps to Health (HL). This eligibility-code string dominates the Health Resources and Services Administration book (1,128 peers, 65% of 1,732).

Code 25
Others (see official listing text)

Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Agency Contact

Department of Health and Human Services, Health Resources and Services Administration ACajina@hrsa.gov

What to do next

Rapid Antiretroviral Therapy is closed; use the parent program and agency catalog for the next funding cycle.

  • Browse open federal opportunities in the same category when this listing is closed. Open opportunities
  • Look up CFDA 93.928 across all indexed listings before you commit to this opportunity alone. Eligibility finder
  • Compare award ranges across federal categories before you pick a single CFDA. All categories

Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Data sourced from the SAM.gov Assistance Listings and Grants.gov. See our methodology for details. Retrieved and formatted by PlainGrants